Syndrome News and Research

RSS

Avasimibe inhibits SARS-CoV-2 and boosts T-cell responses

Researchers demonstrate that avasimibe-mediated inhibition of ACAT blocks the entry and fusion of SARS-CoV-2 in different cell types.

18 Apr 2022

Role of cGAS-STING in SARS-CoV-2 infection

A new study analyzes the activation of cGAS and STING can induce a type I IFN response due to SARS-CoV-2 infection.

15 Apr 2022

Durable neutralizing response against Omicron after heterologous vaccine boosting

Researchers assess the impact of homologous and heterologous primary-booster vaccine dose combinations.

15 Apr 2022

Genomic characterization of the circulating SARS-CoV-2 lineages in Papua New Guinea

A recent study characterized the SARS-CoV-2 lineages circulating in Papua New Guinea during the second wave of COVID-19.

15 Apr 2022

Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease

Researchers investigated the longevity and intensity of the SARS-CoV-2 vaccine immune response in patients suffering from immune-mediated inflammatory diseases.

15 Apr 2022

Comparison of neutralizing antibody response following SARS-CoV-2 booster vaccination with breakthrough infection

A new study examined the serological immune responses and antibody-dependent cell-mediated phagocytosis in individuals who had either received two doses of a standard vaccine regime, a booster dose following the regime, or a breakthrough infection following vaccination.

15 Apr 2022

Insight into the future of genetic testing

In this interview, we speak to Sheetal Parmar, vice president of medical affairs and head of clinical services at Natera, about their cell-free DNA (cfDNA) testing services.

From Natera 15 Apr 2022

Vaccine breakthrough infections with omicron sub-lineages induce cross-neutralizing antibodies

A new study evaluated the cross-neutralizing potency of serum samples collected from individuals who have been infected with the omicron variant of SARS-CoV-2.

14 Apr 2022

Orally delivered temperature-stable tablet vaccine efficacy against SARS-CoV-2 and other respiratory infections

Researchers assessed the protective efficacy of the temperature-stable orally delivered vaccines against respiratory viral pathogens.

14 Apr 2022

About one in four adults has a liver condition that is a risk factor for heart disease

It is estimated that about one in four adults worldwide has a liver condition that is a risk factor for heart disease, according to a new American Heart Association scientific statement published today in the Association's peer-reviewed journal Arteriosclerosis, Thrombosis, and Vascular Biology.

14 Apr 2022

Study explores role of APOBEC-mediated RNA editing in SARS-CoV-2 fitness

A new study investigated whether APOBEC proteins can directly edit the RNA sequence of SARS-CoV-2 to generate C-to-U mutations.

14 Apr 2022

Recent advances in non-viral nano-vector delivery of CRISPR/Cas9 genome editing payloads

Researchers reviewed non-viral nano-vectors used for delivering the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas9-mediated genome editing system.

14 Apr 2022

The preclinical potential of S. miltiorrhiza extracts for the treatment of COVID-19

In a recent study, researchers assessed the anti-COVID-19 efficacy of Salvia miltiorrhiza Bunge.

14 Apr 2022

Study finds dexamethasone and remdesivir treatment in hospitalized COVID-19 patients is associated with reduced neurological complications

Researchers investigated the potential of therapeutic drugs, remdesivir and dexamethasone, when used alone or in combination on neurological complications that arise in COVID-19 affected individuals.

14 Apr 2022

COVID-19 may affect a group of biochemical reactions called one-carbon metabolism

Scientific statement from the American Heart Association on COVID-19 and cardiovascular complications in children and adolescents

A recent scientific statement published in Circulation reviewed the current knowledge on COVID-19.

13 Apr 2022

Syndrome News and Research

Avasimibe inhibits SARS-CoV-2 and boosts T-cell responses

Role of cGAS-STING in SARS-CoV-2 infection

Durable neutralizing response against Omicron after heterologous vaccine boosting

Genomic characterization of the circulating SARS-CoV-2 lineages in Papua New Guinea

Intensity and longevity of SARS-CoV-2 vaccination response in patients with immune-mediated inflammatory disease

Comparison of neutralizing antibody response following SARS-CoV-2 booster vaccination with breakthrough infection

Insight into the future of genetic testing

Vaccine breakthrough infections with omicron sub-lineages induce cross-neutralizing antibodies

Orally delivered temperature-stable tablet vaccine efficacy against SARS-CoV-2 and other respiratory infections

About one in four adults has a liver condition that is a risk factor for heart disease

Study explores role of APOBEC-mediated RNA editing in SARS-CoV-2 fitness

Recent advances in non-viral nano-vector delivery of CRISPR/Cas9 genome editing payloads

The preclinical potential of S. miltiorrhiza extracts for the treatment of COVID-19

Study finds dexamethasone and remdesivir treatment in hospitalized COVID-19 patients is associated with reduced neurological complications

COVID-19 may affect a group of biochemical reactions called one-carbon metabolism

Dietary influences on long COVID in children

Structural differences between SARS-CoV-1 and SARS-CoV-2 RBDs

Novel transdermal vaccine delivery for COVID-19 and cancer

CDC study highlights effectiveness of COVID-19 booster vaccination against reinfection and hospitalization

Scientific statement from the American Heart Association on COVID-19 and cardiovascular complications in children and adolescents

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest News